• 1
    Agostinis, P., K. Berg, K. A. Cengel, T. H. Foster, A. W. Girotti, S. O. Gollnick, S. M. Hah, M R. Hamblin, A. Juzeniene, D. Kessel, M. Korbelik, J. Moan, P. Mroz, D. Nowi, J. Piette, B. C. Wilson and J. Golab (2011) Photodynamic therapy of cancer: An update. CA-Cancer J. Clin. 61, 250281.
  • 2
    Robertson, C. A., D. H. Evans and H. Abraharnse (2009) Photodynamic therapy (PDT): A short review on cellular mechanisms and cancer research applications for PDT. J. Photochem. Photobiol., B 96, 18.
  • 3
    Wilson, B. C. and M. S. Patterson (2008) The physics, biophysics and technology of photodynamic therapy. Phys. Med. Biol. 53, R61R109.
  • 4
    Juzeniene, A., Q. Peng and J. Moan (2007) Milestones in the development of photodynamic therapy and fluorescence diagnosis. Photochem. Photobiol. Sci. 6, 12341245.
  • 5
    Grossweiner, L. I. (2005) The Science of Phototherapy: An Introduction. Springer-Verlag, The Netherlands.
  • 6
    Dolmans, D. E. J. G. J., D. Fukumura and R. K. Jain (2003) Photodynamic therapy for cancer. Nat. Rev. Cancer 3, 380387.
  • 7
    Dougherty, T. J., C. J. Gomer, B. W. Henderson, G. Jori, D. Kessel, M. Korbelik, J. Moan and Q. Peng (1998) Photodynamic therapy. J. Natl Cancer Inst. 90, 889905.
  • 8
    Castano, A. P., T. N. Demidova and M. R. Hamblin (2005) Mechanisms in photodynamic therapy: Part two-cellular signaling, cell metabolism and modes of cell death. Photodiagn. Photodyn. Ther. 2, 123.
  • 9
    Oleinick, N. L., R. L. Morris and T. Belichenko (2002) The role of apoptosis in response to photodynamic therapy: What, where, why, and how. Photochem. Photobiol. Sci. 1, 121.
  • 10
    Augustin, A. J., S. Scholl and J. Kirchhof (2009) Treatment of neovascular age-related macular degeneration: Current therapies. Clin. Ophthalmol. 3, 175182.
  • 11
    Szacilowski, K., W. Macyk, A. Drzewiecka-Matuszek, M. Brindell and G. Stochel (2005) Bioinorganic photochemistry: Frontiers and mechanisms. Chem. Rev. 105, 26472694.
  • 12
    Castano, A. P., T. N. Demidova and M. R. Hamblin (2004) Mechanisms in photodynamic therapy: Part one-photosensitizers, photochemistry and cellular localization. Photodiagn. Photodyn. Ther. 1, 279293.
  • 13
    Ethirajan, M., Y. Chen, P. Joshi and R. K. Pandey (2011) The role of porphyrin chemistry in tumor imaging and photodynamic therapy. Chem. Soc. Rev. 40, 340362.
  • 14
    Sternberg, E. D., D. Dolphin and C. Bruckner (1998) Porphyrin-based photosensitizers for use in photodynamic therapy. Tetrahedron 54, 41514202.
  • 15
    Detty, M. R., S. L. Gibson and S. J. Wagner (2004) Current clinical and preclinical photosensitizers for use in photodynamic therapy. J. Med. Chem. 47, 38973915.
  • 16
    Blumenkranz, M. S., K. W. Woodburn, F. Qing, S. Verdooner, D. Kessel and R. Miller (2000) Lutetium texaphyrin (lu-tex): A potential new agent for ocular fundus angiography and photodynamic therapy. Am. J. Ophthalmol. 129, 353362.
  • 17
    Collins, H. A., M. Khurana, E. H. Moriyama, A. Mariampillai, E. Dahlstedt, M. Balaz, M. K Kuimova, M. Drobizhev, V. X. D. Yang, D. Phillips, A. Rebane, B. C. Wilson and H. L. Anderson (2008) Blood-vessel closure using photosensitizers engineered for two-photon excitation. Nat. Photonics 2, 420424.
  • 18
    Dahlstedt, E., H. A. Collins, M. Balaz, M. K. Kuimova, M. Khurana, B. C. Wilson, D. Phillips and H. L. Anderson (2009) One- and two-photon activated phototoxicity of conjugated porphyrin dimers with high two-photon absorption cross sections. Org. Biomol. Chem. 7, 897904.
  • 19
    Kuimova, M. K., H. A. Collins, M. Balaz, E. Dahlstedt, J. A. Levitt, N. Sergent, K. Suhling, M. Drobizhev, N. S. Makarov, A. Rebane, H. L. Anderson and D. Phillips (2009) Photophysical properties and intracellular imaging of water-soluble porphyrin dimers for two-photon excited photodynamic therapy. Org. Biomol. Chem. 7, 889896.
  • 20
    Pawlicki, M., H. A. Collins, R. G. Denning and H. L. Anderson (2009) Two-photon absorption and the design of two-photon dyes. Angew. Chem. Int. Ed. 48, 32443266.
  • 21
    Samkoe, K. S. and D. T. Cramb (2003) Application of an ex vivo chicken chorioallantoic membrane model for two-photon excitation photodynamic therapy of age-related macular degeneration. J. Biomed. Opt. 8, 410417.
  • 22
    Khurana, M., H. A. Collins, A. Karotki, H. L. Anderson, D. T. Cramb and B. C. Wilson (2007) Quantitative in vitro demonstration of two-photon photodynamic therapy using Photofrin® and Visudyne®. Photochem. Photobiol. 83, 14411448.
  • 23
    Buytaert, E., M. Dewaele and P. Agostinis (2007) Molecular effectors of multiple cell death pathways initiated by photodynamic therapy. Biochim. Biophys. Acta Rev. Cancer 1776, 86107.
  • 24
    Castano, A. P., T. N. Demidova and M. R. Hamblin (2005) Mechanisms in photodynamic therapy: Part three—Photosensitizer pharmacokinetics, biodistribution, tumor localization and modes of tumor destruction. Photodiagn. Photodyn. Ther. 2, 91106.
  • 25
    Kessel, D. (2004) Delivery of photosensitizing agents. Adv. Drug Deliv. Rev. 56, 78.
  • 26
    Boyle, R. W. and D. Dolphin (1996) Structure and biodistribution relationships of photodynamic sensitizers. Photochem. Photobiol. 64, 469485.
  • 27
    Hamblin, M. R. and E. L. Newman (1994) On the mechanism of the tumor-localizing effect in photodynamic therapy. J. Photochem. Photobiol., B 23, 38.
  • 28
    Kessel, D. and K. Woodburn (1993) Biodistribution of photosensitizing agents. Int. J. Biochem. 25, 13771383.
  • 29
    Balaz, M., H. A. Collins, E. Dahlstedt and H. L. Anderson (2009) Synthesis of hydrophilic conjugated porphyrin dimers for one-photon and two-photon photodynamic therapy at NIR wavelengths. Org. Biomol. Chem. 7, 874888.
  • 30
    Kim, A., M. Roy, F. Dadani and B. C. Wilson (2010) A fiberoptic reflectance probe with multiple source-collector separations to increase the dynamic range of tissue optical absorption and scattering measurements. Opt. Expr. 18, 55805594.
  • 31
    Fritsch, C., G. Goerz and T. Ruzicka (1998) Photodynamic therapy in dermatology. Arch. Dermatol. 134, 207214.
  • 32
    Mahmoud, B. H., C. L. Hexsel, T. H. Hamzavi and H. W. Lim (2008) Effects of visible light on the skin. Photochem. Photobiol. 84, 450462.
  • 33
    Dougherty, T. J., M. T. Cooper and T. S. Mang (1990) Cutaneous phototoxic occurrences in patients receiving photofrin. Lasers Surg. Med. 10, 485488.
  • 34
    Kessel, D., R. Luguya and M. G. H. Vicente (2003) Localization and photodynamic efficacy of two cationic porphyrins varying in charge distribution. Photochem. Photobiol. 78, 431435.
  • 35
    Ogilby, P. R. (2010) Singlet oxygen: There is indeed something new under the sun. Chem. Soc. Rev. 39, 31813209.
  • 36
    Hatz, S., J. D. C. Lambert and P. R. Ogilby (2007) Measuring the lifetime of singlet oxygen in a single cell: Addressing the issue of cell viability. Photochem. Photobiol. Sci. 6, 11061116.
  • 37
    Peng, Q., J. Moan and J. M. Nesland (1996) Correlation of subcellular and intratumoral photosensitizer localization with ultrastructural features after photodynamic therapy. Ultrastruct. Pathol. 20, 109129.
  • 38
    Baker, M. (2010) The whole picture. Nature 463, 977980.
  • 39
    Pogue, B. W. and G. Burke (1998) Fiber-optic bundle design for quantitative fluorescence measurement from tissue. Appl. Opt. 37, 74297436.
  • 40
    Igarashi, A., H. Konno, T. Tanaka, S. Nakamuraa, Y. Sadzuka, T. Hirano and Y. Fujise (2003) Liposomal photofrin enhances therapeutic efficacy of photodynamic therapy against the human gastric cancer. Toxicol. Lett. 145, 133141.
  • 41
    Kuimova, M. K., M. Hoffmann, M. U. Winters, M. Eng, M. Balaz, I. P. Clark, H. A. Collins, S. M. Tavender, C. J. Wilson, B. Albinsson, H. L. Anderson, A. W. Parker and D. Phillips (2007) Determination of the triplet state energies of a series of conjugated porphyrin oligomers. Photochem. Photobiol. Sci. 6, 675682.